Skip to main content
SpringerLink
Log in

Nuklearmedizinische Möglichkeiten in Primärdiagnostik und Follow-up

  • Chapter
Pleuramesotheliom

  • 275 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 9.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Benard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest 1998; 114: 713–722

    CAS  PubMed  Google Scholar 

  • Benard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Prognostic value of FDG PET imaging in malignant pleural mesothelioma. J Nucl Med 1999; 40: 1241–1245

    CAS  PubMed  Google Scholar 

  • Blankenberg FG, Katsikis PD, Tait JF et al. Imaging of apoptosis (programmed cell death) with 99 mTc annexin V. J Nucl Med 1999; 40: 184–191

    CAS  PubMed  Google Scholar 

  • Blankenberg FG, Katsikis PD, Tait JF et al. In vivo detection and imaging of phosphatidylserine expression during programmed cell death. Proc Natl Acad Sci USA 1998; 95: 6349–6354

    Article  CAS  PubMed  Google Scholar 

  • Blankenberg FG, Naumovski L, Tait JF, Post AM, Strauss HW. Imaging cyclophosphamide-induced intramedullary apoptosis in rats using 99mTc-radiolabeld annexin V. J Nucl Med 2001; 42: 309–316

    CAS  PubMed  Google Scholar 

  • Buchmann I, Guhlmann CA, Elsner K, Gfrorer W, Schirrmeister H, Kotzerke J, Buck A, Reske SN. F-18-FDG PET for primary diagnosis differential diagnosis of pleural processes. Nuklearmedizin 1999; 38: 319–322

    CAS  PubMed  Google Scholar 

  • Carretta A, Landoni C, Melloni G, Ceresoli GL, Compierchio A, Fazio F, Zannini P. 18-FDG positron emission tomography in the evaluation of malignant pleural diseases — a pilot study. Eur J Cardiothorac Surg 2000; 17: 377–383

    Article  CAS  PubMed  Google Scholar 

  • Coppock DL, Pardee AB. Control of thymidine kinase mRNA during the cell cycle. Mol Cell Biol 1987; 7: 2925–2932

    CAS  PubMed  Google Scholar 

  • Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2003; 126: 11–16

    Article  PubMed  Google Scholar 

  • Garcia MJ, Arbizu J, Ramirez JC, Robledo C, Domper M, Richter J. Extracardiac activity with Tl-201 in a pleural mesothelioma recurrence. Clin Nucl Med 1991; 16: 595

    CAS  PubMed  Google Scholar 

  • Gerbaudo VH, Sugarbaker DJ, Britz-Cunningham S, Di Carli MF, Mauceri C, Treves ST. Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. J Nucl Med 2002; 43: 1144–1149

    PubMed  Google Scholar 

  • Haberkorn U, Altmann A, Morr I et al. Gene therapy with herpes simplex virus thymidine kinase in hepatoma cells: uptake of specific substrates. J Nucl Med 1997; 38: 287–294

    CAS  PubMed  Google Scholar 

  • Haberkorn U, Bellemann ME, Gerlach L et al. Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinase. Gene Ther 1998; 5: 880–887

    Article  CAS  PubMed  Google Scholar 

  • Haberkorn U, Kinscherf R, Krammer PH, Mier W, Eisenhut M. Investigation of a potential scintigraphic marker of apoptosis: radioiodinated Z-Val-Ala-DL-Asp(O-Methyl)-fluoromethyl ketone. Nucl Med Biol 2001; 28: 793–798

    CAS  PubMed  Google Scholar 

  • Haberkorn U, Strauss LG, Dimitrakopoulou A et al. PET studies of fluorodeoxyglucose metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991; 32: 1485–1490

    CAS  PubMed  Google Scholar 

  • Haberkorn U, Strauss LG, Dimitrakopoulou A et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 1993; 34: 12–17

    CAS  PubMed  Google Scholar 

  • Haberkorn U, Ziegler SI, Oberdorfer F et al. FDG uptake, tumor proliferation and expression of glycolysis associated genes in animal tumor models. Nucl Med Biol 1994; 21: 827–834

    CAS  PubMed  Google Scholar 

  • Ho L, Sugarbaker DJ, Skarin AT. Malignant pleural mesothelioma. Cancer Treat Res 2001; 105: 327–373

    CAS  PubMed  Google Scholar 

  • Hustinx R, Shiue CY, Alavi A et al. Imaging in vivo herpes simplex virus thymidine kinase gene transfer to tumourbearing rodents using positron emission tomography and [18F]FHPG. Eur J Nucl Med 2001; 28: 5–12

    Article  CAS  PubMed  Google Scholar 

  • Marom EM, Erasmus JJ, Pass HI, Patz EF Jr. The role of imaging in malignant pleural mesothelioma. Semin Oncol 2002; 29: 26–35

    Article  PubMed  Google Scholar 

  • Mier W, Haberkorn U, Eisenhut M. [18F]FLT; Portrait of a proliferation marker. Eur J Nucl Med 2002; 29: 165–169

    Article  CAS  Google Scholar 

  • Nishikimi T, Ochi H, Hirota K, Ikuno Y, Oku H, Takeuchi K, Takeda T. Primary pericardial mesothelioma detected by gallium-67 scintigraphy. J Nucl Med 1987; 28: 1210–1212

    CAS  PubMed  Google Scholar 

  • Ruiz Hernandez G, Garcia Garcia T, Azagra Ros P et al. Pelvic and lumbar metastasis detected by bone scintigraphy in malignant pleural mesothelioma. Nuklearmedizin. 1999; 38: 68–71

    CAS  PubMed  Google Scholar 

  • Saito Y, Price R, Rottenberg DA, Fox JJ, Su TL, Watanabe KA, Philipps FA. Quantitative autoradiographic mapping of herpes simplex virus encephalitis with radiolabeled antiviral drug. Science 1982; 217: 1151–1153

    CAS  PubMed  Google Scholar 

  • Schneider DB, Clary-Macy C, Challa S et al. Positron emission tomo-graphy with F-18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2000; 120: 128–133

    Article  CAS  PubMed  Google Scholar 

  • Sherley JL, Kelly TJ. Regulation of human thymidine kinase during the cell cycle. J Biol Chem 1988; 263: 8350–8358

    CAS  PubMed  Google Scholar 

  • Shields AF, Grierson JR, Dohmen BM et al. Imaging proliferation in vivo with [F-18]FLT and positron emission tomography. Nat Med 1998; 4: 1334–1336

    Article  CAS  PubMed  Google Scholar 

  • Swayne LC, Hediger RG, Wolff M Bone scan detection of pelvic metastasis from pleural mesothelioma. Clin Nucl Med 1992; 17: 965–966

    CAS  PubMed  Google Scholar 

  • Teirstein AS, Chahinian P, Goldsmith SJ, Sorek M. Gallium scanning in differentiating malignant from benign asbestos-related pleural disease. Am J Ind Med 1986; 9: 487–494

    CAS  PubMed  Google Scholar 

  • Watanabe N, Shimizu M, Kameda K, Kanazawa T, Seto H. Thallium-201 scintigraphy in malignant mesothelioma. Br J Radiol 1999; 72: 308–310

    CAS  PubMed  Google Scholar 

  • Yamamoto T, Seino Y, Fukumoto H et al. Over-expression of facilitative glucose transporter genes in human cancer. Biochem Biophys Res Comm 1990; 170: 223–230

    Article  CAS  PubMed  Google Scholar 

  • Yoshida S, Fukumoto M, Motohara T, Oobayashi K, Takada Y, Tsubota N, Sashikata T. Ga-67 tumor scan in malignant diffuse mesothelioma — comparison with CT and pathological findings. Ann Nucl Med 1999; 13: 49–54

    CAS  PubMed  Google Scholar 

  • Zhuang H, Pourdehnad M, Lambright ES et al. Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processes. J Nucl Med 2001; 42: 1412–1417

    CAS  PubMed  Google Scholar 

  • Zubeldia J, Abou-Zied M, Nabi H Evaluation of Patients with Known Mesothelioma with 18F-Fluorodeoxyglucose and PET. Comparison with Computed Tomography. Clin Positron Imaging 2000; 3: 165

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Radiologische Universitätsklinik, Abteilung Nuklearmedizin, Ruprecht-Karls-Universität Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg

    U. Haberkorn

Authors
  1. U. Haberkorn
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer Medizin Verlag Heidelberg

About this chapter

Cite this chapter

Haberkorn, U. (2005). Nuklearmedizinische Möglichkeiten in Primärdiagnostik und Follow-up. In: Pleuramesotheliom. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-27329-8_3

Download citation

  • DOI: https://doi.org/10.1007/3-540-27329-8_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-23014-4

  • Online ISBN: 978-3-540-27329-5

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation